Table 3.

Changes in physiological outcomes (categorical variables) between intervention and control groups

	Proportion (%) of participants achieving goal at baseline			Proportion (%) of participants achieving goal after intervention			Change (endpoint baseline) (%)		Adjusted OR (95% CI)*	P value
	Intervention	Control	P value†	Intervention	Control	P value†	Intervention	Control
HbA1c <7%	37.1	40.7	0.244	55.0	47.5	0.015	17.9	6.8	1.94 (1.35 to 2.81)	<0.001
BMI <24 kg/m2	39.3	39.7	0.940	44.7	40.2	0.147	5.4	0.5	1.79 (1.13 to 2.85)	0.013
FPG <7.0 mmol/L	45.5	44.6	0.810	51.9	44.2	0.012	6.4	−0.4	1.70 (1.20 to 2.39)	0.002
BP <140/80 mm Hg	43.6	34.3	0.002	43.4	34.7	0.004	−0.2	0.4	1.34 (0.97 to 1.85)	0.079
Triglyceride <1.7 mmol/L	64.5	60.6	0.202	66.5	56.2	<0.001	2.0	−4.4	1.57 (1.03 to 2.40)	0.036
HDL (>1.0 mmol/L for men and >1.3 mmol/L for women)	62.9	66.8	0.196	73.9	69.6	0.128	11.0	2.8	1.74 (1.15 to 2.62)	0.008
LDL <2.6 mmol/L	43.5	34.3	0.002	43.6	34.2	0.002	0.1	−0.1	1.32 (0.93 to 1.87)	0.122
Total cholesterol <4.5 mmol/L	40.6	32.8	0.008	44.3	36.7	0.012	3.7	3.9	1.23 (0.88 to 1.72)	0.225

*OR and 95% CI, estimated with mixed-effects models, presents the likelihood of achieving target goal among intervention participants compared with control participants at study end.

†χ² tests for categorical variables between intervention and control groups.

BMI, body mass index; BP, blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein.